STOCK TITAN

Schedule 13G: Anson Discloses 573,538-Share Position in APDN

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Applied DNA Sciences (APDN) discloses that a group of affiliated investment entities and individuals led by Anson controls 573,538 shares, representing 8.2% of the outstanding common stock on a diluted basis including warrants. The filing states the position is held in the ordinary course of business and not for the purpose of changing control. Shared voting and dispositive power over the 573,538 shares is reported, with no sole voting or dispositive power claimed. The filing identifies the reporting persons and their organizational domiciles and clarifies warrant exercise limitations considered in the ownership percentage.

Positive

  • Material disclosure of a >5% stake (573,538 shares, 8.2% diluted) provides clarity to investors
  • Position reported as passive under Schedule 13G, indicating no declared intent to change control

Negative

  • None.

Insights

TL;DR: Anson group holds an 8.2% diluted stake in APDN with shared voting power; position reported as passive.

The disclosure shows a notable passive stake above the 5% threshold, which can attract investor attention without signaling control intentions. The 8.2% figure is calculated on a diluted base including warrants and factors in ownership limitations that cap exercise to 4.99% or 9.99% for certain warrants. Shared voting and dispositive power indicates coordinated influence among the reporting persons rather than unilateral control. Because the filing is a Schedule 13G, the group asserts passive intent, reducing immediate governance implications but making the stake material for market watchers and potential future activist interest.

TL;DR: Group ownership is material but claimed passive; shared authority may warrant monitoring for future changes in intent.

The filing identifies multiple affiliated entities and individuals with shared control over the position, and it explicitly states the securities were not acquired to influence control. This classification under Schedule 13G signals no current intent to pursue board or control actions. The inclusion of warrant-based dilution and exercise limitations is important for governance analysis because actual voting influence could change if warrants are exercised subject to the stated ceilings. Investors concerned with board composition should note the combined ownership and the potential for coordinated action despite the passive claim.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Anson Funds Management LP
Signature:/s/ Tony Moore
Name/Title:Tony Moore, Manager
Date:08/14/2025
Anson Management GP LLC
Signature:/s/ Tony Moore
Name/Title:Tony Moore, Manager
Date:08/14/2025
Tony Moore
Signature:/s/ Tony Moore
Name/Title:Tony Moore, Manager
Date:08/14/2025
Anson Advisors Inc.
Signature:/s/ Amin Nathoo
Name/Title:Amin Nathoo, Director
Date:08/14/2025
Signature:/s/ Moez Kassam
Name/Title:Moez Kassam, Director
Date:08/14/2025
Amin Nathoo
Signature:/s/ Amin Nathoo
Name/Title:Amin Nathoo, Director
Date:08/14/2025
Moez Kassam
Signature:/s/ Moez Kassam
Name/Title:Moez Kassam, Director
Date:08/14/2025

FAQ

How many APDN shares does Anson report beneficially owning?

The filing reports beneficial ownership of 573,538 shares of APDN common stock.

What percentage of APDN does the Anson group own?

The reported ownership represents 8.2% of APDN on a diluted basis including warrants.

Does the filing indicate Anson intends to influence control of APDN?

No; the Schedule 13G states the securities are held in the ordinary course of business and were not acquired to change or influence control.

Do the reporting persons hold sole voting power over the shares?

No; the filing shows 0 sole voting power and shared voting power for the 573,538 shares.

Are warrants included in the ownership calculation?

Yes; the 8.2% figure includes shares issuable upon exercise of warrants and accounts for exercise limitations on those warrants.
Applied Dna Scie

NASDAQ:APDN

APDN Rankings

APDN Latest News

APDN Latest SEC Filings

APDN Stock Data

7.26M
1.28M
1.11%
6.92%
8.4%
Diagnostics & Research
Services-testing Laboratories
Link
United States
STONY BROOK